In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw

J Pharmacol Exp Ther. 2009 Sep;330(3):756-63. doi: 10.1124/jpet.109.155762. Epub 2009 Jun 26.

Abstract

It has been demonstrated that kinin B(1) receptors are highly up-regulated under several stressful stimuli, such as infection. However, there is no evidence indicating whether Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) might lead to B(1) receptor up-regulation. In this study, we demonstrate that Pg-LPS injection into the rat paw resulted in a marked functional up-regulation of B(1) receptors (as measured by an increase of B(1) receptor-induced edema), which was preceded by a rapid rise in B(1) receptor mRNA expression. The local administration of Pg-LPS also resulted in a prominent production of the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha), followed by an increase of neutrophil influx; both events were observed at periods before B(1) receptor induction. The functional and molecular Pg-LPS-elicited B(1) receptor up-regulation was significantly reduced by the glucocorticoid dexamethasone (0.5 mg/kg s.c.), and to a lesser extent by the chimeric anti-TNF-alpha antibody infliximab (1 mg/kg s.c.). Of high relevance, we show for the first time that a single administration of the proresolution lipid mediator (5S,12R,18R)-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid (resolvin E1; 300 ng/rat i.p.) was able to markedly down-regulate Pg-LPS-driven B(1) receptor expression, probably by inhibiting TNF-alpha production and neutrophil migration. Collectively, the present findings clearly suggest that Pg-LPS is able to induce the up-regulation of B(1) receptors through mechanisms involving TNF-alpha release and neutrophil influx, which are largely sensitive to resolvin E1. It is tempting to suggest that kinin B(1) receptors might well represent a pivotal pathway for the inflammatory responses evoked by P. gingivalis and its virulence factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antibodies, Monoclonal / pharmacology
  • Bradykinin / analogs & derivatives
  • Bradykinin / pharmacology
  • Dexamethasone / pharmacology
  • Edema / chemically induced
  • Edema / metabolism
  • Edema / pathology
  • Eicosapentaenoic Acid / analogs & derivatives
  • Eicosapentaenoic Acid / pharmacology
  • Foot / pathology
  • Infliximab
  • Lipopolysaccharides / pharmacology*
  • Male
  • Neutrophil Infiltration / drug effects
  • Neutrophils / drug effects
  • Neutrophils / enzymology
  • Peroxidase / metabolism
  • Porphyromonas gingivalis / chemistry*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Rats, Wistar
  • Receptor, Bradykinin B1 / biosynthesis*
  • Receptor, Bradykinin B1 / drug effects
  • Up-Regulation / drug effects

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Lipopolysaccharides
  • RNA, Messenger
  • Receptor, Bradykinin B1
  • bradykinin, des-Arg(9)-
  • Dexamethasone
  • Eicosapentaenoic Acid
  • Infliximab
  • Peroxidase
  • 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
  • Bradykinin